From Symptom Control to Targeted Treatment: The Shifting Paradigm of Atopic Dermatitis Evolve Registration
From Symptom Control to Targeted Treatment, Webinar June 5, 2017 at 8pm Eastern

Dr. Peter Lio and Dr. Robert Sidbury will engage in a lively discussion about challenges and opportunities in atopic dermatitis care today. In light of new research, they will discuss the presentation of AD across different ages, assess comorbidities, and talk about evolving approaches to management of this chronic disease.

THANK YOU FOR YOUR INTEREST
THIS EVENT HAS ENDED

IMPORTANT: Users must pre-register on the Evolve website in order to participate in this activity and receive credit. Each participant will be required to take a pre-test before viewing the webinar. After watching the webinar, each participant will be required to review a brief statement confirming that s/he participated in the live webinar, then take the post-test to receive a certificate.

Target Audience
This certified CME activity is designed for dermatologists, dermatology nurse practitioners and dermatology physician assistants involved in the management of atopic dermatitis.

Learning Objectives
Upon completion of this activity, the participant should be able to:
    • Identify the mechanisms of action, efficacy, and safety of emerging targeted therapies for AD.
    • Recognize the lifestyle measures and daily skin care practices that are the foundation of AD treatment plans.
    • Discuss the prevalence, presentation, and quality-of-life effects of AD in adults.
    • Interpret and explain the recognized and emerging comorbidities associated with AD in children, adolescents, and adults.

Accreditation Statement
Evolve Medical Education LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA Credit Designation Statement
Evolve Medical Education LLC designates this live activity for a maximum of 1 AMA PRA Category 1 Credit.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Grantor Statement
Supported by an unrestricted educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals. Evolve Logo